Research use only

In stock · depth page

TB-500 / thymosin β4 fragment context (RUO)

Thymosin β4 literature identity · TB-500 catalog alias

BPC-157 10 mg + TB-500 10 mg blend · alias note

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.

Peer-reviewed literature overwhelmingly uses thymosin β4, not the vendor alias TB-500. Confirm sequence and mass on the lot COA before the blend is released to the bench.

Naming map

Thymosin β4 / Tβ4 is the full-length endogenous peptide discussed in regenerative reviews. TB-500 is the research-catalog alias associated with thymosin β4 or related fragment language. The blend vial is BPC-157 plus that reference at 10 mg + 10 mg: one SKU line, dual identity on the certificate.

No primary analytical paper is listed that equates every commercial TB-500 lot to full-length thymosin β4. Match sequence and mass on the lot COA.

Write TB-500 / thymosin β4 per the lot COA on internal receiving notes. Request mass-spec identity and HPLC purity for the blend lot. Do not substitute a GH-axis secretagogue for a repair-class purchase order.

Identity

Form

Lyophilized blend, sealed vial

Strength

10 mg + 10 mg lyophilized blend

Purity

≥99% HPLC (see the lot COA)

CAS

  • Thymosin β4 / TB-500: 77591-33-4

PubMed

Selected literature

  • PMID 22074294 (2012) Goldstein & Kleinman, Expert Opinion on Biological Therapy — thymosin β4 multi-functional regenerative review
  • PMID 25921810 (2017) Kim et al., Journal of Tissue Engineering and Regenerative Medicine — thymosin β4 in a dermal burn-wound model

Recent literature (2023–2026): No primary analytical paper is listed that equates every commercial TB-500 lot to full-length thymosin β4. Match sequence and mass on the lot COA.

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Bench reconstitution

The catalog parent is one lyophilized cake: 10 mg BPC-157 and 10 mg TB-500. Dissolve the entire cake in one bacteriostatic-water volume to the combined mg/mL the protocol specifies. Swirl until no solids remain. Do not vortex. Record solvent lot and time. This is a reconstitution volume, not a clinical dose, and it is not a standalone BPC-157 or TB-500 vial.

Diluent page: bacteriostatic water.

Storage

Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.

Certificate of analysis

Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.

Lab FAQ

Can the laboratory order TB-500 only from this parent?

No. The catalog parent is the blend. There is no standalone TB-500 SKU on this page. Write request@pharmapeptidesrx.com for lot documents. This page does not publish prices or banking details. Invoices go out from request@ only.

In this library

In stock · list price

Request from the catalog

Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.